Breast Cancer

In addition to treatment-related risks, some survivors discover they have a genetic syndrome that may lead to a second cancer.

Updates from the 2006 annual meeting of the American Society of Clinical Oncology.

Young adult survivor Molly McMaster turns her experience into a national tour and non-profit group dedicated to raising awareness on colon cancer.

Eight years after its approval, Herceptin emerges as the best weapon against HER2-positive breast cancer.

A closer look at bioidentical hormones and why one pharmaceutical company wants the FDA to keep a closer eye on them.

From mastectomy to reconstruction and beyond.

The challenges of breast cancer in women under 40.

The progress made in genetic testing for breast cancer.

Women with a history of breast cancer should not take HRT.